ArticleStem cell research & therapy2025

Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity.

Yuma Fukutani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.